CE Holdings Co.,Ltd. (TYO:4320)
645.00
+9.00 (1.42%)
Apr 24, 2025, 3:30 PM JST
CE Holdings Revenue
CE Holdings had revenue of 3.80B JPY in the quarter ending December 31, 2024, with 19.78% growth. This brings the company's revenue in the last twelve months to 15.18B, up 10.60% year-over-year. In the fiscal year ending September 30, 2024, CE Holdings had annual revenue of 14.55B with 6.76% growth.
Revenue (ttm)
15.18B
Revenue Growth
+10.60%
P/S Ratio
0.65
Revenue / Employee
25.05M
Employees
606
Market Cap
9.86B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 14.55B | 922.00M | 6.76% |
Sep 30, 2023 | 13.63B | -70.00M | -0.51% |
Sep 30, 2022 | 13.70B | 1.42B | 11.54% |
Sep 30, 2021 | 12.28B | 1.68B | 15.85% |
Sep 30, 2020 | 10.60B | -1.05B | -8.99% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 838.60B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Shionogi & | 456.87B |